News for 'Viral Research'

India records 22,775 Covid cases in 24 hrs, Omicron tally 1,431

India records 22,775 Covid cases in 24 hrs, Omicron tally 1,431

Rediff.com1 Jan 2022

Of the 1,431 patients infected with the Omicron variant of the virus so far, 374 have either recuperated or migrated, according to the ministry's data updated at 8 am.

India's Omicron count rises to 422; active Covid cases lowest since Mar 2020

India's Omicron count rises to 422; active Covid cases lowest since Mar 2020

Rediff.com26 Dec 2021

As many as 422 Omicron cases have been detected across 17 states and Union Territories in India so far and 130 of these people have recovered or migrated, according to Union health ministry data updated on Sunday.

Maha slashes charges for COVID-19 tests by private labs

Maha slashes charges for COVID-19 tests by private labs

Rediff.com13 Jun 2020

Maharashtra Health Minister Rajesh Tope said the lowering of rates for the tests would provide a relief to the people.

Daily COVID-19 cases in India lowest in 571 days

Daily COVID-19 cases in India lowest in 571 days

Rediff.com14 Dec 2021

The number of fresh cases of the coronavirus infection has been recorded below 15,000 for the last 47 days now.

India may ease clinical trial norms for coronavirus vaccine

India may ease clinical trial norms for coronavirus vaccine

Rediff.com1 Apr 2020

The Central Drugs Standard Control Organisation said while the rights, safety, and well-being of trial subjects were of paramount importance, protocol amendment, deviation or modification might be necessary in some cases owing to unavoidable circumstances.

Hail the power of networks!

Hail the power of networks!

Rediff.com15 Apr 2020

Not just in the fight against COVID-19, but also in politics, economics and society, observes Ajit Balakrishnan.

Covid cases with variants of concern rose from 10% in May to 51% till June 20

Covid cases with variants of concern rose from 10% in May to 51% till June 20

Rediff.com28 Jun 2021

The panel was informed that the economic impact of the second wave of viral infection was "asynchronous in its onset and wider in its spread particularly in rural hinterland", a source said.

Khan Sir, man behind Bihar students' agitation who no one knows

Khan Sir, man behind Bihar students' agitation who no one knows

Rediff.com28 Jan 2022

The authorities in Bihar have registered an FIR against Khan Sir and five teachers for allegedly inciting violence over the controversy surrounding the results of tests conducted by the RRB-NTPC after the recent violent protests in Patna.

Scientists recommend 40% humidity to curb COVID-19 spread

Scientists recommend 40% humidity to curb COVID-19 spread

Rediff.com21 Aug 2020

In their review of studies, published in the journal Aerosol and Air Quality Research, the scientists specifically drew focus on relative humidity, which is a measure of water vapour in the air compared to the total saturation of vapour that can exist in the air at its current temperature.

Herd immunity difficult to achieve: AIIMS Director

Herd immunity difficult to achieve: AIIMS Director

Rediff.com21 Feb 2021

Experts say herd immunity is said to have been developed in a population segment if at least 50-60 per cent of those are found to have the presence of antibodies in a sero-prevalence survey.

India records 41,649 fresh Covid cases, 593 deaths

India records 41,649 fresh Covid cases, 593 deaths

Rediff.com31 Jul 2021

The number of active cases has gone up to 408920, accounting for 1.29 per cent of the total number of cases, while the national COVID-19 recovery rate was recorded at 97.37 per cent, the data showed.

Coronavirus can last on face masks for a week: Study

Coronavirus can last on face masks for a week: Study

Rediff.com6 Apr 2020

'If you want to protect yourself just maintain good hygiene, wash your hands often and try not to touch your face, your mouth or nose without cleaning first'

India records 35,342 Covid new cases, 483 deaths in 24 hours

India records 35,342 Covid new cases, 483 deaths in 24 hours

Rediff.com23 Jul 2021

The number of active cases has declined to 4,05,513, accounting for 1.3 per cent of the total caseload, while the national COVID-19 recovery rate was recorded at 97.36 per cent, the ministry's data updated at 8 am showed.

COVID vaccine likely to be available by first of 2021: Choubey

COVID vaccine likely to be available by first of 2021: Choubey

Rediff.com19 Sep 2020

Responding to another question, Choubey said that the phase-I of clinical trials have revealed excellent safety of the two candidate vaccines indigenously developed by Bharat Biotech in collaboration with Indian Council of Medical Research and Cadila Healthcare Ltd, and now their immunogenicity testing is in progress. Their phase II clinical trials are ongoing.

Cambridge kicks off vaccine race to fight all coronaviruses

Cambridge kicks off vaccine race to fight all coronaviruses

Rediff.com26 Aug 2020

The new vaccine candidate, DIOS-CoVax2, uses banks of genetic sequences of all known coronaviruses, including those from bats, believed to be the natural hosts of many relatives of human coronaviruses.

Men more likely to suffer severe effects of COVID-19 than women: Study

Men more likely to suffer severe effects of COVID-19 than women: Study

Rediff.com29 Apr 2020

Based on the observations, scientists said that additional care may be required for older men or those with underlying conditions. Yang and his team analysed several patient datasets to see if there were differences in how men and women respond to COVID-19.

Johnson & Johnson says its Covid shot neutralises Delta variant

Johnson & Johnson says its Covid shot neutralises Delta variant

Rediff.com2 Jul 2021

In the ensemble trial, Johnson & Johnson's vaccine was 85 per cent effective against severe/critical disease and demonstrated protection against hospitalisation and death. The vaccine was consistently effective across all regions studied globally, including in South Africa and Brazil, where there was a high prevalence of rapidly emerging Beta and Zeta variants during the study period.

Over 50,000 new Covid cases reported; 1,258 dead in 24 hrs

Over 50,000 new Covid cases reported; 1,258 dead in 24 hrs

Rediff.com27 Jun 2021

A single-day rise of 50,040 fresh COVID-19 infections took India's tally to 3,02,33,183, while the number of active cases dipped to 5,86,403, according to the Union health ministry data on Sunday.

Can't allow unvaccinated people on public transport: Maha govt to HC

Can't allow unvaccinated people on public transport: Maha govt to HC

Rediff.com22 Dec 2021

The decision to prohibit people, who were yet to receive both doses of COVID-19 vaccine, from using public transport in the state had been taken to ensure those unvaccinated do not endanger the lives of others, it said.

India's Feluda COVID test cheaper alternative to RT-PCR, say scientists

India's Feluda COVID test cheaper alternative to RT-PCR, say scientists

Rediff.com28 Sep 2020

Named after Satyajit Ray's famed detective, the Feluda test, which is priced at Rs 500 and can deliver a result in 45 minutes, is able to differentiate SARS-CoV-2 from other coronaviruses even if genetic variations between them are minute.

Lancet Study finds Russian vaccine safe, effective

Lancet Study finds Russian vaccine safe, effective

Rediff.com4 Sep 2020

Results from early-phase non-randomised vaccine trials in a total of 76 people show that two formulations of the vaccine have a good safety profile detected over 42 days, and induce antibody responses in all participants within 21 days.

China exonerates itself in whitepaper on COVID-19

China exonerates itself in whitepaper on COVID-19

Rediff.com7 Jun 2020

A whitepaper released by the Chinese government gave a lengthy explanation to refute the allegations of cover up and delay by Beijing on reporting the COVID-19 outbreak last year in Wuhan. United States President Donald Trump and leaders of several countries have accused China of not being transparent in reporting the deadly disease, leading to huge human casualties and economic crisis across the world.

Virus cannot be man made: Wuhan lab denies coronavirus link

Virus cannot be man made: Wuhan lab denies coronavirus link

Rediff.com19 Apr 2020

'Never believed that we humans have the capability at this time to create such a virus'

'Surveillance can't go down because the curve is going down'

'Surveillance can't go down because the curve is going down'

Rediff.com29 Dec 2020

'Even after vaccines are given, precautions like using a mask and maintaining social distancing have to be taken.'

Covaxin found to neutralise 617 Covid variant: Dr Fauci

Covaxin found to neutralise 617 Covid variant: Dr Fauci

Rediff.com28 Apr 2021

The New York Times on Tuesday said Covaxin works by teaching the immune system to make antibodies against the SARS-CoV-2 coronavirus. The antibodies attach to viral proteins, such as the so-called spike proteins that stud its surface.

'No need to give special attention to COVID-19 anymore'

'No need to give special attention to COVID-19 anymore'

Rediff.com22 Aug 2022

'All actions for COVID-19 should be the same as for other routine health conditions.' 'There is no need to report the matter in the media all the time; not on front page please.'

That's Irrfan, folks!

That's Irrfan, folks!

Rediff.com3 Apr 2019

'As I leave my footprints onto these steps of my life, I want to pause to be grateful for receiving your immense love and support.'

'No preparedness planning, no accountability, no action plan'

'No preparedness planning, no accountability, no action plan'

Rediff.com8 May 2021

'This government did not have any plan for safety stocks of essential medicines.'

Textile firms get ready to stitch 'anti COVID' clothing line

Textile firms get ready to stitch 'anti COVID' clothing line

Rediff.com1 Aug 2020

To cater to the antiviral fabrics and antimicrobial segment, almost all the Indian big textiles brands, including Reliance, Arvind, Aditya Birla, Donear Group, Raymond, and Siyaram have entered the market. Companies started their journey with reusable masks and PPE kits, and today, they are offering a range of PPE clothing along with fashion and casualwear.

'Emergence of another coronavirus is inevitable'

'Emergence of another coronavirus is inevitable'

Rediff.com13 May 2020

'The worst case scenario is a rebound of the virus.' 'Life is not going to be what it was.' 'Life as we know it has changed forever.' 'The new normal therefore is test, trace and treat.'

'Only 4 drugs reduce COVID-19 mortality. Everything else is stupidity'

'Only 4 drugs reduce COVID-19 mortality. Everything else is stupidity'

Rediff.com18 Jun 2021

'Unfortunately, during this pandemic, everybody started saying that well, these are desperate times and desperate times need desperate solutions.' 'Purely out of fear, anxiety, panic, this knowledge that people started acquiring from WhatsApp University and social media, it pushed science completely to the backseat.'

Does Siddha medicine have a Covid cure?

Does Siddha medicine have a Covid cure?

Rediff.com8 Aug 2020

'Not one single, but multiple trials are there to quote. However, these will be published as scientific manuscripts.' 'This includes integrative as well as standalone approaches in Covid mitigation.'

Sharjeel Imam's brother questioned by cops in Bihar

Sharjeel Imam's brother questioned by cops in Bihar

Rediff.com28 Jan 2020

He had been involved in organising the protests at Shaheen Bagh but came into limelight after a video clip went viral wherein he could be heard making some disturbing comments while addressing a gathering at Aligarh Muslim University, following which he was booked under the sedition charge in the UP town.

Covaxin output scaled up to 500 million jabs a year: Bharat Biotech

Covaxin output scaled up to 500 million jabs a year: Bharat Biotech

Rediff.com17 May 2021

This apart, to further increase capacities, Bharat Biotech has partnered with Indian Immunologicals (IIL) to manufacture the drug substance for Covaxin. The technology transfer process is underway and IIL has the 'capabilities and expertise' to manufacture the inactivated viral vaccines at commercial scale.

How to DEFEAT the NEXT Pandemic

How to DEFEAT the NEXT Pandemic

Rediff.com3 Nov 2021

Illustrious international thinkers met at the Milken Institute Global Conference 2021 and many discussions addressed the impact of the COVID-19 pandemic on the world at large.

COVID-19 vaccine race: Where they stand currently

COVID-19 vaccine race: Where they stand currently

Rediff.com9 Jan 2021

As India prepares to launch its vaccine drive on January 16, here is a look at the options:

Cadila believes it has silver bullet to fight COVID-19

Cadila believes it has silver bullet to fight COVID-19

Rediff.com21 Apr 2020

Can Interferon alfa-2b treat COVID-19 effectively?

IMA cautions Centre on 'end of pandemic' remark

IMA cautions Centre on 'end of pandemic' remark

Rediff.com8 Mar 2021

The association's reaction came after Union Health Minister Harsh Vardhan on Sunday said that the country is "in the end game of the COVID-19 pandemic" and Delhi Health Minister Satyendar Jain said the coronavirus is nearing an "endemic" phase in the national capital.

COVID-19: The threat from people with no symptoms

COVID-19: The threat from people with no symptoms

Rediff.com14 May 2020

'Testing is a very good strategy if only symptomatic people are transmitting the disease.' 'Here asymptomatic people, with minimum, trivial symptoms, are transmitting too.' 'Testing, treating, tracing contacts and quarantining them -- yes, it will work up to a certain extent.' 'But more important is physical distancing, hand hygiene, cough etiquette and cocooning, protecting with reverse quarantining the most vulnerable people, senior citizens, people with other major medical problems.' 'To me, that makes much more sense.'

Govt issues advisory for rational use of Remdesivir

Govt issues advisory for rational use of Remdesivir

Rediff.com7 Jun 2021

The government on Monday issued an advisory for rational use of Remdesivir in COVID-19 treatment, underlining that the anti-viral drug must be advised by senior faculty members directly involved in the patient's care.